静脉-动脉体外膜氧合中缺血性与出血性卒中的流行病学
该研究基于ELSO登记数据库,纳入2012至2021年间534个国际中心的成人V-A ECMO患者(排除体外心肺复苏)。33,041例患者中20,297例有死亡率数据,12,327例纳入逻辑回归。结果显示缺血性卒中发生率上升(p<0.0001),出血性卒中发生率保持稳定,总体90天死亡率下降(p<0.0001)。较高的24小时PaO2及较大的ECMO前PaCO2与插管后24小时PaCO2差值均与缺血性卒中发生率增加相关,而年病例量与之无关;两种卒中均与90天死亡率增加相关(均p<0.0001),较高的年病例量与较低的90天死亡率相关(p=0.001)。
要点
- 2012至2021年V-A ECMO患者缺血性卒中发生率上升(p<0.0001),出血性卒中发生率稳定,总体90天死亡率下降(p<0.0001)。
- 缺血性卒中和出血性卒中均与90天死亡率增加相关(均p<0.0001)。
- 较高的24小时PaO2和较大的ECMO前PaCO2与插管后24小时PaCO2差值均与缺血性卒中发生率增加相关。
- 较高的年病例量与较低的90天死亡率相关(p=0.001),但与缺血性/出血性卒中发生率无关。
- V-A ECMO期间死亡风险在最初数天最高。
适用人群与场景
- 2012至2021年间534个国际中心的成人V-A ECMO患者,排除体外心肺复苏。
红旗征与不能漏的情况
- 缺血性卒中和出血性卒中均与90天死亡率增加相关(均p<0.0001)。
研究设计与关键结果
- 研究类型:基于ELSO登记数据库的回顾性分析,纳入534个国际中心2012至2021年成人V-A ECMO患者,排除体外心肺复苏;33,041例患者中20,297例有死亡率数据,12,327例纳入逻辑回归。
- 主要终点结果:2012至2021年间缺血性卒中发生率上升(p<0.0001),出血性卒中发生率保持稳定,总体90天死亡率下降(p<0.0001)。
- 危险因素:较高的24小时PaO2和较大的ECMO前PaCO2与插管后24小时PaCO2差值均与缺血性卒中发生率增加相关,而年病例量与之无关。
- 结局关联:缺血性/出血性卒中均与90天死亡率增加相关(均p<0.0001)。
- 中心效应:较高的年病例量与较低的90天死亡率相关(p=0.001)。
- 生存分析:V-A ECMO期间死亡风险在最初数天最高。
证据类型、等级与局限
- 证据类型:基于ELSO登记数据库的回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: While venoarterial extracorporeal membrane oxygenation (V-A ECMO) provides lifesaving support for cardiopulmonary failure, complications may increase mortality, with few studies focusing on ischemic/hemorrhagic stroke. We aimed to determine the trends and associations of stroke incidence and mortality, and their risk factors, including the effects of annual case volumes of ECMO centers.
METHODS: Retrospective analysis was performed on the Extracorporeal Life Support Organization (ELSO) registry, including adult V-A ECMO patients from 534 international centers between 2012 and 2021, excluding extracorporeal cardiopulmonary resuscitation. Temporal trend analyses were performed for stroke incidence and mortality. Univariate testing, multivariable regression, and survival analysis were used to evaluate the associations of stroke, 90-day mortality, and impact of annual center volume.
RESULTS: Of 33,041 patients, 20,297 had mortality data, and 12,327 were included in the logistic regression. Between 2012 and 2021, ischemic stroke incidence increased (p < 0.0001), hemorrhagic stroke incidence remained stable, and overall 90-day mortality declined (p < 0.0001). Higher 24-h PaO2 and greater decrease between pre-ECMO PaCO2 and post-cannulation 24-h PaCO2 were associated with greater ischemic stroke incidence, while annual case volume was not. Ischemic/hemorrhagic strokes were associated with increased 90-day mortality (both p < 0.0001), while higher annual case volume was associated with lower 90-day mortality (p = 0.001). Hazard of death was highest in the first several days of V-A ECMO.
CONCLUSION: In V-A ECMO patients between 2012 and 2021, 90-day mortality decreased, while ischemic stroke incidence increased. ELSO centers with higher annual case volumes had lower mortality, but were not associated with ischemic/hemorrhagic stroke incidence. Both ischemic/hemorrhagic strokes were associated with increased mortality.
参考来源
- Hwang J, Kalra A, Shou BL, et al. Epidemiology of ischemic stroke and hemorrhagic stroke in venoarterial extracorporeal membrane oxygenation. Crit Care. 2023. PMID: 37946237. doi:10.1186/s13054-023-04707-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。